Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercebiotech.com
FierceBiotech
Get the latest updates from FierceBiotech directly as they happen.
Follow now 337 followers
Latest posts
Last updated about 9 hours ago
Merck KGaA institutes in-office requirement for US research team that could lead to 70 layoffs
about 9 hours ago
Merck KGaA’s U.S. research site has instituted a new in-office work requirement...
FDA releases 14 new drug rejection letters after 3-month pause in transparency policy
about 12 hours ago
The FDA has published 14 new rejection letters for drug applications, mere...
Q32’s stock jumps 60% on latest phase 2 alopecia data for potential rival to JAK inhibitors
about 13 hours ago
The latest phase 2 readout for Q32 Bio’s alopecia hopeful received a...
Agenus scraps phase 3 colorectal study after 3 months to narrow focus to colon cancer
about 15 hours ago
Agenus has scrapped a phase 3 study of its combo therapy in...
Insilico’s Chinese partner returns for $177M pact to explore ‘mass market’ CNS indication
about 18 hours ago
Pharma platform company China Medical System Holdings has tapped up existing partner...
Apnimed dreams of IPO to fund launch of sleep apnea pill on FDA's desk
about 21 hours ago
Apnimed is having sweet dreams of an IPO that could fund the...
‘How did they get there first?’ Biotechs forced to learn new patent tricks to protect pipelines
1 day ago
For a biotech, your intellectual property is your most prized asset. But...
KKR-backed Allyntra debuts to serve medtech industry as it announces new CEO
1 day ago
KKR, the global investment giant, has launched Allyntra as a new, precision-engineered...
IHealthScreen nabs FDA nod for AI-backed dx to spot mild diabetic retinopathy
1 day ago
IHealthScreen hauled in FDA 510(k) clearance for its AI-powered diagnostic that detects...
GSK sees phase 3 win for Hansoh-partnered ADC in China as validating its ‘priority asset’
4 days ago
Hansoh Pharmaceutical’s pair of much-hyped ADCs continue to justify partner GSK’s decision...
Chutes & Ladders—Idorsia locks in new CEO after shakeup
4 days ago
After Idorsia’s former chief, Srishti Gupta, M.D., left the company upon “mutual...
Bausch + Lomb gives up on glaucoma eye drop hopeful after phase 2 fail
4 days ago
Bausch + Lomb has abandoned its next great hope in glaucoma after...